SWA

Shockwave Med

Stock
Stock
Ticker: SWAV
SWAV

Price

Price

CHART BY

Frequently asked questions

Shockwave Med's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 4.27. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover Shockwave Med's stock, with a consensus target price of $335.00. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Shockwave Med reported a revenue of $787.97M.
Shockwave Med's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $177.21M. EBITDA measures the company's overall financial performance.
Shockwave Med has a free cash flow of $166.14M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Shockwave Med employs approximately 1,468 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

Financials

EPS (TTM) 
4.27
Revenue (TTM) 
$787.97M
EBITDA (TTM) 
$177.21M
Free Cashflow (TTM) 
$166.14M

Analyst Ratings

The price target is $335.00 and the stock is covered by 1 analysts.

Buy

0

Hold

1

Sell

0

Information

Shockwave Medical, Inc. operates as a medical device company, which concentrates on developing and commercializing products intended to transform the way classified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.

Employees
1,468
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
SWAV

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation